PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-438.75%
Negative net income growth while EQT stands at 94.36%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-11.24%
Both reduce yoy D&A, with EQT at -18.37%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
147.62%
Some yoy growth while EQT is negative at -30.91%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
154.17%
SBC growth while EQT is negative at -9.97%. John Neff would see competitor possibly controlling share issuance more tightly.
-21400.00%
Negative yoy working capital usage while EQT is 100.67%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-100.00%
AR is negative yoy while EQT is 91.11%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21400.00%
Negative yoy usage while EQT is 87.59%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-101.55%
Negative yoy while EQT is 106.96%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-52.86%
Negative yoy CFO while EQT is 102.28%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
8.33%
Lower CapEx growth vs. EQT's 19.06%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-93.52%
Negative yoy acquisition while EQT stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
2206.45%
Purchases growth of 2206.45% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-80.38%
We reduce yoy sales while EQT is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
10.70%
Less 'other investing' outflow yoy vs. EQT's 80.50%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-178.01%
We reduce yoy invests while EQT stands at 19.06%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
33.33%
Debt repayment well below EQT's 89.92%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.